Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neurodegenerative diseases treatment strategy.
2019/33/N/NZ7/01875
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński, Collegium Medicum
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 17 – announced on 2019-03-15
- Amount awarded
- 139 700 PLN
- Project start date
- 2020-02-17
- Project end date
- 2023-02-16
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives.
- Authors:
- Drop M, Koczurkiewicz-Adamczyk P, Bento O, Pietruś W, Satała G, Blicharz-Futera K, Canale V, Grychowska K, Bantreil X, Pękala E, Kurczab R, Bojarski AJ, Chaumont-Dubel S, Marin P, Lamaty F, Zajdel P.
- Academic press:
- European Journal of Medicinal Chemistry (year: 2024, volume: 275, pages: 116615), Publisher: Elsevier Masson SAS
- Status:
- Published
- DOI:
- 10.1016/j.ejmech.2024.116615 – link to the publication